Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02510599 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
A Phase 2 study, sponsored by Melinta Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT02510599 is a Phase 2 study that has completed, run by Melinta Therapeutics. The registered enrollment target is 10 participants.
The verdict
NCT02510599, a Phase 2 study, has completed, sponsored by Melinta Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of solithromycin on hepatic histology and biomarkers in patients with nonalcoholic steatohepatitis.
Interventions
- DRUG solithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-02-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02510599
The ClinicalTrials.gov registry entry for NCT02510599 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Melinta Therapeutics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which solithromycin is the first listed.
NCT02510599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02510599 about?
NCT02510599 is a clinical study titled "Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis". The purpose of this study is to evaluate the effects of solithromycin on hepatic histology and biomarkers in patients with nonalcoholic steatohepatitis.
What is the current status of trial NCT02510599?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2015-12. Estimated completion is 2017-02-28.
What interventions are being tested in trial NCT02510599?
The interventions under investigation include: solithromycin (DRUG).
Who is sponsoring clinical trial NCT02510599?
This trial is sponsored by Melinta Therapeutics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.